Tag: biotechnology

Unity Biotechnology reports Q4 EPS (50c) vs. (28c) last year

Cash Position and Operational Outlook As of December 31, 2024, Unity reported total cash, cash equivalents, and marketable securities amounting to $23.2 million, marking a...

Nautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026

Nautilus Biotechnology: Navigating Challenges and Embracing Innovation Strategic Restructuring for Sustainability Nautilus Biotechnology has taken a significant step to ensure its long-term sustainability by restructuring its...

Popular Articles